Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Non-Current Liabilities (2016 - 2020)

Niagen Bioscience (NAGE) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $250000.0 as the latest value for Q2 2020.

  • Quarterly Other Non-Current Liabilities fell 14.68% to $250000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $250000.0 through Jun 2020, down 14.68% year-over-year, with the annual reading at $169000.0 for FY2019, 38.55% down from the prior year.
  • Other Non-Current Liabilities for Q2 2020 was $250000.0 at Niagen Bioscience, up from $238000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $503850.0 in Q3 2017, with the low at $155000.0 in Q3 2018.
  • Average Other Non-Current Liabilities over 5 years is $286329.8, with a median of $275000.0 recorded in 2018.
  • The sharpest move saw Other Non-Current Liabilities tumbled 63.28% in 2018, then surged 79.7% in 2019.
  • Over 5 years, Other Non-Current Liabilities stood at $389010.0 in 2016, then dropped by 19.28% to $314000.0 in 2017, then dropped by 12.42% to $275000.0 in 2018, then tumbled by 38.55% to $169000.0 in 2019, then skyrocketed by 47.93% to $250000.0 in 2020.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $250000.0, $238000.0, and $169000.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.